Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
April 11, 2003
Lessons from the first patient with an implanted pacemaker: 1958-2001
Berit Larsson, Håkan Elmqvist, Lars Rydén, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 17, 2003
Clinical experience with an automatic threshold tracking algorithm study
Charles Kennergren, Berit Larsson, Asa Uhrenius, et al.
Journal of the American Geriatrics Society
|
October 1, 2016
Fall Risk Assessment Predicts Fall-Related Injury, Hip Fracture, and Head Injury in Older Adults
Martin Nilsson, Joel Eriksson, Berit Larsson, et al.
Calcified Tissue International
|
May 7, 2018
Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study
Berit Larsson, Dan Mellström, Lisa Johansson, et al.
European Urology Focus
|
March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Trials
|
June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
European Urology Oncology
|
April 22, 2025
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
Nature Medicine
|
August 28, 2024
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Nature Medicine
|
August 20, 2024
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pacing and Clinical Electrophysiology : PACE
|
April 11, 2003
Lessons from the first patient with an implanted pacemaker: 1958-2001
Berit Larsson, Håkan Elmqvist, Lars Rydén, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 17, 2003
Clinical experience with an automatic threshold tracking algorithm study
Charles Kennergren, Berit Larsson, Asa Uhrenius, et al.
Journal of the American Geriatrics Society
|
October 1, 2016
Fall Risk Assessment Predicts Fall-Related Injury, Hip Fracture, and Head Injury in Older Adults
Martin Nilsson, Joel Eriksson, Berit Larsson, et al.
Calcified Tissue International
|
May 7, 2018
Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study
Berit Larsson, Dan Mellström, Lisa Johansson, et al.
European Urology Focus
|
March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Trials
|
June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
European Urology Oncology
|
April 22, 2025
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
Nature Medicine
|
August 28, 2024
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Nature Medicine
|
August 20, 2024
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Page
of 1